Sulzer Medica's Carbo-Seal approved by FDA:
This article was originally published in Clinica
Executive Summary
Sulzer Medica's Carbo-Seal ascending aortic prosthesis has been approved by the FDA for marketing in the US. Developed by Sulzer Carbomedics and Sulzer Vascutek, the device combines the bileaflet aortic Carbomedics prosthetic heart valve and the woven, gelatin-sealed, low-taper Vascutek Gelweave graft. The prosthesis eliminates the need to pre-clot or pre-treat the graft prior to implantation.